Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2010 | 12-2009 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -15,291 | -4,539 | N/A |
| Depreciation Amortization | 2,340 | 125 | N/A |
| Other Working Capital | -3,066 | 40 | N/A |
| Other Operating Activity | 10,803 | 891 | 0 |
| Operating Cash Flow | $-5,214 | $-3,484 | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | N/A | -3 | N/A |
| Investing Cash Flow | $N/A | $-3 | $N/A |
| Cash Flows From Financing Activities | |||
| Change In Short Term Borrowing | 3,524 | 1,723 | N/A |
| Debt Issued | 1,751 | 1,905 | N/A |
| Common Stock Issued | 15,184 | N/A | N/A |
| Other Financing Activity | -755 | -77 | 0 |
| Financing Cash Flow | $19,704 | $3,552 | $N/A |
| Beginning Cash Position | 81 | 16 | N/A |
| End Cash Position | 14,571 | 81 | N/A |
| Net Cash Flow | $14,490 | $65 | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -5,214 | -3,484 | N/A |
| Capital Expenditure | N/A | -3 | N/A |
| Free Cash Flow | -5,214 | -3,487 | 0 |